KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Revenue (2016 - 2025)

Cme (CME) has disclosed Revenue for 17 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 8.09% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.5 billion, a 6.37% increase, with the full-year FY2025 number at $6.5 billion, up 6.37% from a year prior.
  • Revenue was $1.6 billion for Q4 2025 at Cme, up from $1.5 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.7 billion in Q2 2025 to a low of $1.1 billion in Q3 2021.
  • A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: fell 17.66% in 2021, then increased 19.17% in 2023.
  • Cme's Revenue stood at $1.1 billion in 2021, then grew by 5.27% to $1.2 billion in 2022, then increased by 19.17% to $1.4 billion in 2023, then grew by 5.98% to $1.5 billion in 2024, then increased by 8.09% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Revenue are $1.6 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.7 billion (Q2 2025).